TNFRSF11A and breast cancer: Interestingly, following the detection of RANK upregulation in BRCA1mut breast malignancies, inhibition of RANK-L by denosumab was found able to restrain progesterone-induced proliferation in a preclinical model of BRCA1mut BC [54].